| 臺大學術典藏 |
2020-02-15T03:53:18Z |
Cost-effectiveness comparison of risk groups: A case study involving acute respiratory distress syndrome (ARDS)
|
Jen, L.-C.;Li, S.-Y.;Kao, K.-C.; Jen, L.-C.; Li, S.-Y.; LICHUNG JEN; Kao, K.-C. |
| 嘉南藥理大學 |
2021 |
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific region
|
Liao, Chia-Te; Yang, Chun-Ting; Toh, Han Siong; Chang, Wei-Ting; Chang, Hung-Yu; Kuo, Fang-Hsiu; Lee, Mei-Chuan; Hua, Yi-Ming; Tang, Hsin-Ju; Strong, Carol; Ou, Huang-Tz |
| 國立成功大學 |
2021-10-9 |
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific region
|
Liao;Chia-Te;Yang;Chun-Ting;Toh;Siong, Han;Chang;Wei-Ting;Chang;Hung-Yu;Kuo;Fang-Hsiu;Lee;Mei-Chuan;Hua;Yi-Ming;Tang;Hsin-Ju;Strong;Carol;Ou;Huang-Tz |
| 國立成功大學 |
2021 |
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia–Pacific region
|
Liao, C.-T.;Yang, C.-T.;Toh, H.S.;Chang, W.-T.;Chang, H.-Y.;Kuo, F.-H.;Lee, M.-C.;Hua, Y.-M.;Tang, H.-J.;Strong, C.;Ou, H.-T. |
| 國立成功大學 |
2021-10-29 |
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region
|
Liao;Chia-Te;Yang;Chun-Ting;Kuo;Fang-Hsiu;Lee;Mei-Chuan;Chang;Wei-Ting;Tang;Hsin-Ju;Hua;Yi-Ming;Chang;Hung-Yu;Chen;Zhih-Cherng;Strong;Carol;Ou;Huang-Tz;Toh;Siong, Han |
| 嘉南藥理大學 |
2021 |
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region
|
Liao, Chia-Te; Yang, Chun-Ting; Kuo, Fang-Hsiu; Lee, Mei-Chuan; Chang, Wei-Ting; Tang, Hsin-Ju; Hua, Yi-Ming; Chang, Hung-Yu; Chen, Zhih-Cherng; Strong, Carol; Ou, Huang-Tz; Toh, Han Siong |
| 國立成功大學 |
2022-03 |
Cost-effectiveness evaluation of mammography screening program in Taiwan: Adjusting different distributions of age and calendar year for real world data
|
Lin;Chia-Ni;Lee;Kuo-Ting;Chang;Sheng-Mao;Wang;Jung-Der |
| 臺大學術典藏 |
2021-06-24T07:16:01Z |
Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
|
Lu C.-Y.;Chung C.-H.;Li-Min Huang;Kruger E.;Tan S.-C.;Zhang X.-H.;Chiu N.-C.; Lu C.-Y.; Chung C.-H.; LI-MIN HUANG; Kruger E.; Tan S.-C.; Zhang X.-H.; Chiu N.-C. |
| 臺大學術典藏 |
2020 |
Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
|
Zhang X.-H.; Tan S.-C.; Kruger E.; Huang L.-M.; Chung C.-H.; CHUN-YI LU; Chun-Yi Lu;Chung C.-H.;Huang L.-M.;Kruger E.;Tan S.-C.;Zhang X.-H.;Chiu N.-C.; Chiu N.-C. |
| 臺大學術典藏 |
2020-12-28T12:03:52Z |
Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan
|
Shau W.-Y.; Weng T.-C.; Li J.Z.; Liu L.Z.; Li Y.-H.; Lin R.-T.; Shyu K.-G.; Yeh S.-J.; Chan L.; Chen C.-H.; HWANG, JUEY-JEN |
